1304 related articles for article (PubMed ID: 19357233)
1. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
2. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
3. Myostatin and muscle fiber size. Focus on "Smad2 and 3 transcription factors control muscle mass in adulthood" and "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size".
Welle SL
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1245-7. PubMed ID: 19357232
[No Abstract] [Full Text] [Related]
4. Smad2 and 3 transcription factors control muscle mass in adulthood.
Sartori R; Milan G; Patron M; Mammucari C; Blaauw B; Abraham R; Sandri M
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1248-57. PubMed ID: 19357234
[TBL] [Abstract][Full Text] [Related]
5. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
Eo H; Reed CH; Valentine RJ
Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
7. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Goodman CA; McNally RM; Hoffmann FM; Hornberger TA
Mol Endocrinol; 2013 Nov; 27(11):1946-57. PubMed ID: 24002653
[TBL] [Abstract][Full Text] [Related]
8. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
9. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
[TBL] [Abstract][Full Text] [Related]
11. Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy.
Tando T; Hirayama A; Furukawa M; Sato Y; Kobayashi T; Funayama A; Kanaji A; Hao W; Watanabe R; Morita M; Oike T; Miyamoto K; Soga T; Nomura M; Yoshimura A; Tomita M; Matsumoto M; Nakamura M; Toyama Y; Miyamoto T
J Biol Chem; 2016 Jun; 291(23):12184-94. PubMed ID: 27129272
[TBL] [Abstract][Full Text] [Related]
12. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy.
Basualto-Alarcón C; Jorquera G; Altamirano F; Jaimovich E; Estrada M
Med Sci Sports Exerc; 2013 Sep; 45(9):1712-20. PubMed ID: 23470307
[TBL] [Abstract][Full Text] [Related]
13. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
14. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
15. SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force.
Watt KI; Jaspers RT; Atherton P; Smith K; Rennie MJ; Ratkevicius A; Wackerhage H
Muscle Nerve; 2010 May; 41(5):624-9. PubMed ID: 20151464
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.
Latres E; Amini AR; Amini AA; Griffiths J; Martin FJ; Wei Y; Lin HC; Yancopoulos GD; Glass DJ
J Biol Chem; 2005 Jan; 280(4):2737-44. PubMed ID: 15550386
[TBL] [Abstract][Full Text] [Related]
17. The collagen derived dipeptide hydroxyprolyl-glycine promotes C2C12 myoblast differentiation and myotube hypertrophy.
Kitakaze T; Sakamoto T; Kitano T; Inoue N; Sugihara F; Harada N; Yamaji R
Biochem Biophys Res Commun; 2016 Sep; 478(3):1292-7. PubMed ID: 27553280
[TBL] [Abstract][Full Text] [Related]
18. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
Fuchs BC; Finger RE; Onan MC; Bode BP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
[TBL] [Abstract][Full Text] [Related]
19. Myostatin signaling regulates Akt activity via the regulation of miR-486 expression.
Hitachi K; Nakatani M; Tsuchida K
Int J Biochem Cell Biol; 2014 Feb; 47():93-103. PubMed ID: 24342526
[TBL] [Abstract][Full Text] [Related]
20. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.
Song K; Wang H; Krebs TL; Danielpour D
EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]